Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

10-Year study tracks 8,000 kids for cancer risk after eczema cream use

NCT ID NCT00568997

First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 27 times

Summary

This study follows 8,000 children aged 2 to 17 with eczema who have used Elidel cream. Researchers want to see if the cream increases the risk of cancer over 10 years. No new treatment is given—this is an observational study to gather safety information.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Registry

    Philadelphia, Pennsylvania, 19104, United States

Conditions

The condition(s) this trial relates to.

atopic eczema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.